NovoCure Ltd (NVCR)
29.01
-0.65
(-2.19%)
USD |
NASDAQ |
Jan 07, 16:00
28.62
-0.39
(-1.34%)
After-Hours: 04:23
NovoCure Shareholders Equity (Quarterly): 360.78M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 39.80B |
| LeMaitre Vascular Inc | 331.07M |
| Insulet Corp | 1.118B |
| Globus Medical Inc | 4.069B |
| Perspective Therapeutics Inc | 328.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.222B |
| Total Liabilities (Quarterly) | 861.20M |
| Debt to Equity Ratio | 1.814 |
| Current Ratio | 1.490 |
| Net Debt Paydown Yield | -1.03% |